Chronic kidney disease trials in Finland

In Finland 9 Also abroad 798

9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
Where
Helsinki
Age
1 year to 17 years
People
10 worldwide
Run by
Hansa Biopharma AB
See details and how to joinNCT05753930 · EU 2022-500230-28-00
Phase 2Not yet taking people in Finland
dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation
Where
Helsinki, Turku
Age
18 years to 64 years
People
36 worldwide
Run by
University Medical Center Groningen
See details and how to joinNCT06072326 · EU 2026-525684-40-01
No phaseTaking people
NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)
Where
Savonlinna
Age
45 years to 55 years
People
1,400
Run by
University of Eastern Finland
See details and how to joinNCT07820800
Phase 3Taking people
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Where
Helsinki, Tampere, Turku
Age
1 year to 18 years
People
100 worldwide
Run by
Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00
Phase 3Taking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Helsinki, Jyväskylä, Oulu, Tampere, Turku
Age
18 years and over
People
7,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
Phase 3Taking people
SACK
Where
Helsinki, Lahti, Oulu, Pori, Tampere, Turku, Vaasa
Age
18 years and over
People
1,281 worldwide
Run by
Karolinska University Hospital
See details and how to join2022-501600-10-00 · EU 2022-501600-10-00
No phaseTaking people
SEDentary Lifestyle, Mortality and Major Adverse Clinical Outcomes in Chronic KIDney Disease
Where
Pori, Turku, Vaasa
Age
40 years and over
People
400
Run by
Turku University Hospital
See details and how to joinNCT06935786
Phase 3Taking people
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
Where
Helsinki, Tampere, Turku
Age
18 years and over
People
1,400 worldwide
Run by
Region Stockholm
See details and how to joinNCT05679024
No phaseTaking people
Prognostic Imaging Biomarkers for Diabetic Kidney Disease
Where
Turku
Age
18 years to 80 years
People
500 worldwide
Run by
University of Leeds
See details and how to joinNCT03716401